19:32:26 EDT Tue 23 Apr 2024
Enter Symbol
or Name
USA
CA



True Leaf Medicine International Ltd
Symbol MJ
Shares Issued 95,369,059
Close 2018-11-28 C$ 0.41
Market Cap C$ 39,101,314
Recent Sedar Documents

True Leaf's Q2 sales at $572,071

2018-11-29 07:55 ET - News Release

Mr. Paul Sullivan reports

TRUE LEAF REPORTS SECOND CONSECUTIVE QUARTER OF RECORD SALES

True Leaf Medicine International Ltd. had its best sales quarter ever for the three months ended Sept. 30, 2018.

The revenues were generated from global sales of the company's legal hemp-based True Leaf Pet products. Sales of the products totalled $572,071, making it the company's second record-setting quarter in a row.

True Leaf also announced that for the first time, it has achieved sales of more than $1-million over two quarters. Revenue for the six months ended Sept. 30, 2018, was $1,063,405 -- the company's highest six-month revenue to date and an increase of 42 per cent from the comparable period in the prior year, which had revenue of $747,846.

The company's European operations contributed $177,734 of total revenue for this six-month period, an increase of 86 per cent over $95,727 for the same period in the prior year.

Revenue growth was primarily fuelled by the company's investment in its international sales team which has expanded the commercial reach of its True Leaf Pet division into new markets. The company's True Hemp product line is now sold in more than 2,800 stores worldwide, including Pets Supplies Plus (USA), PetSmart Canada and Pets Corner UK.

"Our growing revenues and the continued success of the True Hemp product line is evidence that pet owners want access to safe, effective and legally compliant therapeutic cannabis products for their pets," said Darcy Bomford, founder and chief executive officer of True Leaf. "We are committed to being the cannabis-for-pets leader in the global pet care industry -- a sector expected to grow to $202.6-billion (U.S.) by 2025 -- by continuing to enter new markets and expanding our product line."

True Leaf pioneered hemp-based pet supplements that provide calming support, promote hip and joint health, and help immune and heart function. The company's True Hemp line of functional treats, supplement oils and chew sticks for dogs and cats are also available on-line on Amazon and True Leaf websites in the United States and Canada. Pet owners in the United Kingdom, France and Germany can shop True Leaf's newly launched direct-to-consumer on-line website.

Q2 2019 financial highlights

For the three-month period ended Sept. 30, 2018

  • True Leaf Pet sales totalled a record $572,071 in the quarter, an increase of 25 per cent over the $458,729 recorded for the same period last year.
  • This is the second consecutive record sales quarter for the company: Earlier this year, True Leaf reported its best quarter ever for the three months ended June 30, 2018. Sales of True Leaf Pet products totalled $491,334 in the quarter, an increase of 70 per cent over the $289,117 recorded for the same period last year.
  • Sylvain Toutant, a retailing expert and former chief executive officer of DavidsTea, was appointed to the company's board of directors.
  • The company announced construction of True Leaf Campus, its cannabis cultivation and production facility in Lumby, B.C., which remains on schedule for late fall 2018 completion.
  • Pioneer cannabis-for-pets veterinarian, Dr. Katherine Kramer, joined True Leaf as founding chair of its veterinary advisory board.
  • Kerry Biggs, CPA, MBA, a former lululemon executive, was appointed chief financial officer of True Leaf.

Recent developments

Highlights subsequent to Q2 2019

  • True Leaf announced it has expanded its global retail presence. Now in 2,800 stores worldwide, True Leaf is also reaching more customers on-line with the launch of direct-to-consumer stores in the United Kingdom, France and Germany.
  • True Leaf Pet launched its first hemp-based product line specially formulated for cats to the European market.

For further information, please refer to the company's management's discussion and analysis for the three-month period ended Sept. 30, 2018, published on the company's website.

About True Leaf Medicine International Ltd.

True Leaf Medicine Inc. is in the final stages of approval to become a licensed producer of federally approved medicinal cannabis for the Canadian market. The licence is subject to a Health Canada inspection to allow for the production, manufacture and distribution of cannabis products upon the completion of the company's cannabis cultivation facility being built in Lumby, B.C. The facility is expected to be completed in late fall 2018.

True Hemp chews, dental sticks and supplement oils are sold in more than 2,800 stores across North America and Europe.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.